DK0872247T3 - Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer - Google Patents

Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer

Info

Publication number
DK0872247T3
DK0872247T3 DK98106340T DK98106340T DK0872247T3 DK 0872247 T3 DK0872247 T3 DK 0872247T3 DK 98106340 T DK98106340 T DK 98106340T DK 98106340 T DK98106340 T DK 98106340T DK 0872247 T3 DK0872247 T3 DK 0872247T3
Authority
DK
Denmark
Prior art keywords
phosphate buffer
formulation containing
topical formulation
containing phosphate
skin permeation
Prior art date
Application number
DK98106340T
Other languages
English (en)
Inventor
Andreas Supersaxo
Original Assignee
Roche Consumer Health Worldwid
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Consumer Health Worldwid filed Critical Roche Consumer Health Worldwid
Application granted granted Critical
Publication of DK0872247T3 publication Critical patent/DK0872247T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98106340T 1997-04-10 1998-04-07 Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer DK0872247T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97105914 1997-04-10

Publications (1)

Publication Number Publication Date
DK0872247T3 true DK0872247T3 (da) 2003-09-29

Family

ID=8226680

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98106340T DK0872247T3 (da) 1997-04-10 1998-04-07 Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer

Country Status (15)

Country Link
US (1) US6420394B1 (da)
EP (1) EP0872247B1 (da)
JP (1) JP4580476B2 (da)
KR (1) KR100554811B1 (da)
CN (1) CN1191826C (da)
AR (1) AR012376A1 (da)
AT (1) ATE243043T1 (da)
BR (1) BR9803300A (da)
CA (1) CA2232855C (da)
DE (1) DE69815585T2 (da)
DK (1) DK0872247T3 (da)
ES (1) ES2201361T3 (da)
PT (1) PT872247E (da)
TR (1) TR199800631A2 (da)
ZA (1) ZA982872B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
WO2004026235A2 (en) * 2002-09-20 2004-04-01 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
WO2004060347A2 (en) * 2002-09-03 2004-07-22 Transform Pharmaceuticals, Inc. Pharmaceutical propylene glycol solvate compositions
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
CA2477923C (en) * 2002-03-01 2021-02-23 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
US20030191187A1 (en) * 2002-04-01 2003-10-09 Lee Fang Yu Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same
US20070059356A1 (en) * 2002-05-31 2007-03-15 Almarsson Oern Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
AU2003243699B2 (en) 2002-06-21 2009-01-15 Transform Pharmaceuticals, Inc. Pharmaceutical compositions with improved dissolution
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
AU2003295846A1 (en) * 2002-11-26 2004-06-18 Transform Pharmaceuticals, Inc. Pharmaceutical formulations of celcoxib
US8183290B2 (en) 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7132452B2 (en) * 2003-03-10 2006-11-07 Fang-Yu Lee Topical formulation having effects on alleviating pain/inflammation caused by herpes virus infection
US20050036953A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of ammonium lactate
US20050042182A1 (en) * 2003-08-13 2005-02-24 Moshe Arkin Topical compositions of urea
US20050037040A1 (en) * 2003-08-13 2005-02-17 Moshe Arkin Topical compositions of urea and ammonium lactate
US20050042268A1 (en) * 2003-07-16 2005-02-24 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050025833A1 (en) * 2003-07-16 2005-02-03 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
US20050020552A1 (en) * 2003-07-16 2005-01-27 Chaim Aschkenasy Pharmaceutical composition and method for transdermal drug delivery
KR101121890B1 (ko) * 2004-11-05 2012-03-19 리도 케미칼 가부시키가이샤 비스테로이드 소염 진통약을 함유하는 비수계 경피흡수제제
US20070287741A1 (en) * 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
US20080220068A1 (en) * 2006-07-31 2008-09-11 Laboratories Besins International Treatment and prevention of excessive scarring
PL2192907T3 (pl) * 2007-08-16 2018-10-31 Remedor Biomed Ltd. Kompozycje erytropoetyny i fibronektyny do zastosowań terapeutycznych
PL214538B1 (pl) 2009-05-28 2013-08-30 P P F Hasco Lek Spolka Akcyjna Kompozycja liposomowa zawierajaca naproksen i sposób wytwarzania kompozycji liposomowej zawierajacej naproksen
WO2011110931A1 (en) * 2010-03-12 2011-09-15 Council Of Scientific & Industrial Research A process for the preparation of inorganic hydrogels with alkali halides
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface
KR20190101140A (ko) * 2018-02-22 2019-08-30 동아제약 주식회사 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
WO2020159676A1 (en) * 2019-01-29 2020-08-06 Bayer Healthcare Llc Topical gel compositions of naproxen

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5829706A (ja) * 1981-08-14 1983-02-22 Toko Yakuhin Kogyo Kk 消炎鎮痛外用剤
JPS6253933A (ja) * 1985-09-02 1987-03-09 Nitto Electric Ind Co Ltd 外皮投与用組成物
JPH085800B2 (ja) * 1986-12-19 1996-01-24 エーザイ株式会社 塩化リゾチ−ム及びグリチルリチン酸ジカリウム含有水溶液製剤
US4720353A (en) * 1987-04-14 1988-01-19 Richardson-Vicks Inc. Stable pharmaceutical w/o emulsion composition
US5183829A (en) * 1991-09-27 1993-02-02 Applied Analytical Industries, Inc. Oral liquid compositions of non-steroidal anti-inflammatory drugs
CA2141192C (en) * 1992-07-28 1999-02-02 Roberta C. Bloom Pharmaceutical composition for topical use containing a crosslinked cationic polymer and an alkoxylated ether
HU220864B1 (en) * 1993-04-16 2002-06-29 Wakamoto Pharma Co Ltd Reversible, thermally gelling water-base medicinal compositions
JPH09500901A (ja) * 1993-07-28 1997-01-28 インサイト・ビジョン・インコーポレイテッド 薬剤供給用懸濁液
JPH07223942A (ja) * 1994-02-03 1995-08-22 Ildong Pharm Co Ltd プロピオン酸系非ステロイド性薬物を有効成分として含有する新規消炎鎮痛外用ゲル製剤
CN1106259A (zh) * 1994-02-05 1995-08-09 日东制药株式会社 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂
DE69528165T2 (de) * 1994-04-21 2003-05-15 Hisamitsu Pharmaceutical Co Transdermal verabreichbare grundlage und daraus hergestelltes transdermal verabreichbares arzneimittel
IT1275955B1 (it) * 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
JPH0967272A (ja) * 1995-08-31 1997-03-11 Advanced Sukin Res Kenkyusho:Kk 局所適用組成物
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
JP2001518879A (ja) * 1997-03-31 2001-10-16 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド 薬剤化合物の向上した浸透性のための溶媒システム

Also Published As

Publication number Publication date
ES2201361T3 (es) 2004-03-16
DE69815585D1 (de) 2003-07-24
AR012376A1 (es) 2000-10-18
CN1195524A (zh) 1998-10-14
EP0872247A1 (en) 1998-10-21
KR100554811B1 (ko) 2006-05-25
CA2232855A1 (en) 1998-10-10
DE69815585T2 (de) 2004-04-29
CN1191826C (zh) 2005-03-09
US6420394B1 (en) 2002-07-16
CA2232855C (en) 2007-10-09
PT872247E (pt) 2003-10-31
TR199800631A3 (tr) 1998-10-21
TR199800631A2 (xx) 1998-10-21
JPH10287588A (ja) 1998-10-27
KR19980081238A (ko) 1998-11-25
JP4580476B2 (ja) 2010-11-10
ATE243043T1 (de) 2003-07-15
EP0872247B1 (en) 2003-06-18
BR9803300A (pt) 2000-01-11
ZA982872B (en) 1998-10-12

Similar Documents

Publication Publication Date Title
DK0872247T3 (da) Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
DK1028961T5 (da) Pleuromutilinderivater som antimikrobielle midler
DK0802184T3 (da) N-Benzyl-2-phenylindoler som østrogene midler
NO963617D0 (no) Gassfylte mikrokapsler til bruk som kontrastmidler
NO983581D0 (no) Lysfiltrerende kosmetisk sammensetning
ID22878A (id) Komposisi aktif secara terapi
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
NO20002162D0 (no) Tienopyrimidin- og tienopyridinderivater nyttige som anticancer midler
ID21482A (id) Turunan-turunan pirazol yang berguna sebagai herbisida
DE601698T1 (de) Topisches Mittel enthaltend Tocopherol.
DK0808833T3 (da) D3-vitamin-analoger
NO984106D0 (no) Azolobenzazepin-derivater som neurologisk aktive midler
DK0975623T3 (da) Indazolamidforbindelser som sertoninerge midler
DK0915819T3 (da) Illudinanaloger anvendt som antitumormiddel
NO20000366D0 (no) O-substituerte hydroksycoumaranon-derivater som anti-tumor- og antimetastase-midler
IT1297886B1 (it) Nifedipina per uso topico
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
NO971955L (no) Nitro-benzamider anvendelige som anti-arrhytmiske midler
NO20002321D0 (no) Bifenylderivater som farmasøytiske midler
FI972585A0 (fi) Virustenvastaisina aineina käyttökelpoiset tienoksatsinonijohdannaiset
NO984307D0 (no) Anvendelsen av spesielle tilberedninger som avskummere
KR950700742A (ko) 이소카르바사이클린류를 활성성분으로써 함유하는 외용 피부치료제 조성물(dermatologic preparation composition containing isocarbacyclin as active ingredint)
IT1296973B1 (it) Formulazione spray per uso topico
ITFE960006U1 (it) Applicazione attiva per uso cosmetico applicazione attiva per uso cosmetico